NHS launches drive to catch pancreatic cancer before symptoms show
Urgent pancreatic cancer tests will be offered by the NHS to those most at risk.
Family doctors will identify patients who could have developed the deadly disease before symptoms emerge.
Pancreatic cancer has the lowest survival rate of all cancers, with just seven per cent living for five years or more because it is typically not detected until it is advanced and harder to treat.
GP teams will comb through patient records to identify anyone over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss.
Figures suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently.
The doctors will contact patients and offer them urgent blood tests and CT scans to either diagnose the cancer or rule it out.
Newly diagnosed diabetes patients often have similar symptoms to a person with early-stage pancreatic cancer because the cancer destroys the same insulin-producing cells that are also affected by diabetes.
Around 10,500 people in the UK are diagnosed with pancreatic cancer every year, and only around one in 20 survive the disease for 10 years or more.
More than half of people die within three months of diagnosis.
More than 300 GP practices in England will be involved in the three-year pilot, which is backed by £2 million in funding and set to be fully operational by this autumn.
Silent symptoms
Prof Peter Johnson, the NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up.
'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment,' he said.
'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.'
Karin Smyth, the health minister, said the 'targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families'.
Alfie Bailey-Bearfield, the head of health improvement at Pancreatic Cancer UK, said earlier diagnosis 'would make the single biggest difference to improving survival'.
'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of the largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so,' he said.
'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those who do, the impact could be lifesaving.'
Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
North Wales Chronicle
17 minutes ago
- North Wales Chronicle
Petition for cancer treatment to be funded reaches 46,000 signatories
The cancer charity Planets is leading the campaign for the treatment, known as selective internal radiation therapy (Sirt), to be made available through the NHS after it was approved for use more than a year ago. A spokesman for the charity said: 'Every year approximately 6,000 people in the UK are diagnosed with NETs, a complex and often slow-growing cancer that can be difficult to detect and treat. 'Many patients develop tumours in the liver where the treatment could offer significant benefits. 'Sirt involves injecting millions of tiny radioactive beads called microspheres – smaller than the width of a human hair – into the blood supply in the liver to destroy cancer cells.' The spokesman said that despite approval by the National Institute for Health and Care Excellence (NICE) in May 2024, NHS England had yet to commission it meaning that patients had no timetable for when it might become available. He added that Sirt was already available on the NHS for patients whose liver cancer developed in the organ directly or which had spread to it from the bowel but NET patients remained excluded. Layla Stephen, a NET patient from Hampshire and director of strategy and finance for Planets, said: 'Patients are missing out simply because of red tape. 'Without NHS commissioning, only those that can afford to go private have access to Sirt and that is simply not right or fair – we need to change this.' Ms Stephen added: 'In a statement earlier this year, NHS England said it was developing a national policy on Sirt to ensure all patients across England have the best possible treatment, yet there is still no confirmed timeline despite approval in May last year, leaving patients in limbo and suffering agonising uncertainty.' Caroline Nokes, Conservative MP for Romsey and Southampton North, has written to health and social care secretary Wes Streeting about the issue. She said: 'Constituents of mine with neuroendocrine tumours should not be caught in a bureaucratic limbo when effective treatment is both available and approved. There needs to be fairness and transparency for these patients.' An NHS spokeswoman said previously: 'The NHS understands the concerns raised about access to selective internal radiation therapy (Sirt) for neuroendocrine tumours in the liver. 'The health service is currently reviewing a clinical proposal and developing a new national mandated NHS policy on Sirt to ensure all patients across England have the best possible treatment for their liver metastases.' The petition can be found at:
South Wales Guardian
19 minutes ago
- South Wales Guardian
170 patients harmed as a result of cyber attack
Pathology services provider Synnovis was the victim of a ransomware attack by a Russian cyber gang in June last year. As a result more than 10,000 appointments were cancelled at the two London NHS trusts that were worst affected. And a significant number of GP practices in London were unable to order blood tests for their patients. Now the Health Service Journal (HSJ) has reported that there were nearly 600 'incidents' linked to the attack, with patient care suffering in 170 of these. This includes one cases of 'severe' harm, 14 which led to 'moderate' harm with the rest identified as 'low harm'. According to NHS guidance severe harm occurs when patients either suffers permanent harm; needs life saving care or could have reduced their life expectancy, among a number of other factors.
The Independent
25 minutes ago
- The Independent
GPs to contact patients with key warning signs of pancreatic cancer
The NHS is rolling out a new initiative across GP surgeries in England, aiming to significantly improve the early detection of pancreatic cancer, a disease with the lowest survival rate among all cancers. Hundreds of GPs will receive additional funding to review patient records, focusing on identifying individuals over the age of 60 who exhibit key warning signs. These include a recent diagnosis of diabetes and unexplained sudden weight loss. Figures suggest that approximately half of all pancreatic cancer diagnoses occur in individuals who have recently been diagnosed with either type 1 or type 2 diabetes. By proactively identifying these high-risk patients, the NHS hopes to diagnose the deadly disease at an earlier, more treatable stage, ultimately improving patient outcomes. Family doctors taking part in the NHS England pilot will then contact patients and send them for urgent blood tests and CT scans to rule cancer in or out. Pancreatic cancer can have vague symptoms and is often diagnosed in the late stages. According to researchers, newly-diagnosed diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. For the new three-year pilot, more than 300 GP practices in England will be involved, with all practices up and running by the autumn. Almost £2 million in targeted funding has been invested to help practices find people most at risk and give patients the best chance of being diagnosed early. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment. 'The NHS is seeing and treating more people with cancer than ever, and early diagnosis is key to ensure patients have the best chance of receiving effective treatment. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth said: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Diagnosing more people with pancreatic cancer earlier, when the disease is most treatable, would make the single biggest difference to improving survival, so we are delighted to see significant further investment from NHS England towards that incredibly important goal. 'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so. 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
